Tekmira Pharmaceuticals Corporation said that it will discontinue the clinical trial of its experimental Ebola drug known as TKM-Ebola-Guinea after reaching a statistical futility boundary. The company concluded that it is unsure whether the treatment helped anyone during the testing.
Tekmira Pharmaceuticals Corporation said that it will discontinue the clinical trial of its experimental Ebola drug known as TKM-Ebola-Guinea after reaching a statistical futility boundary. The company concluded that it is unsure whether the treatment helped anyone during the testing.
Share this Article
Recommended